Institute of Tropical Medicine Antwerp
Foundation of Public Utility

Schistosomiasis control in Ghana: case management and means for diagnosis and treatment within the health system

DSpace/Manakin Repository

Show simple item record

dc.contributor.author van der Werf, M. en_US
dc.contributor.author Bosompem, K. M. en_US
dc.contributor.author de Vlas, S. J. en_US
dc.date.accessioned 2007-12-06T14:34:25Z
dc.date.available 2007-12-06T14:34:25Z
dc.date.issued 2003 en_US
dc.identifier.issn 0035-9203 en_US
dc.identifier.doi http://dx.doi.org/10.1016/S0035-9203(03)90102-7
dc.identifier.other ITG-PLB en_US
dc.identifier.other PARAS en_US
dc.identifier.other U-SCHISTO en_US
dc.identifier.other JIF en_US
dc.identifier.other DOI en_US
dc.identifier.other ABSTRACT en_US
dc.identifier.uri http://hdl.handle.net/10390/327
dc.description.abstract An essential component of integrated schistosomiasis control as promoted by WHO is adequate clinical care for patients presenting at health care facilities. We evaluated the functioning of the Ghanaian health system for diagnosis and treatment of schistosomiasis by interviewing health workers from 70 health care facilities in 4 geographical areas in April and May 2000. Results from presentation of 4 hypothetical cases and a subsequent interview demonstrated that patients presenting with symptoms related to schistosomiasis have a small chance of receiving adequate treatment: often health workers do not recognize the symptoms, especially those of Schistosoma mansoni; patients are frequently referred for a diagnostic test or treatment with a large risk of non-compliance; and praziquantel was not available in 78% of the health care facilities with reported schistosomiasis in their coverage area. The overall cost of treatment is considerable: [symbol: see text] 2.13 for S. haematobium and [symbol: see text] 1.81 for S. mansoni patients, with drug costs contributing approximately 40% of the total cost. To better meet WHO recommendations for passive case detection as part of integrated schistosomiasis control, the Ghanaian health system needs to emphasize training of health workers in schistosomiasis case recognition and case management and increase the availability of praziquantel. Experience from other West African countries indicate that this is feasible. en_US
dc.language English en_US
dc.publisher Elsevier
dc.subject Helminthic diseases en_US
dc.subject Schistosomiasis en_US
dc.subject Schistosoma mansoni en_US
dc.subject Schistosoma haematobium en_US
dc.subject Integrated control en_US
dc.subject Case detection en_US
dc.subject Health personnel en_US
dc.subject Performance en_US
dc.subject Case management en_US
dc.subject Drug availability en_US
dc.subject Praziquantel en_US
dc.subject Cost analysis en_US
dc.subject Ghana en_US
dc.subject Africa, West en_US
dc.title Schistosomiasis control in Ghana: case management and means for diagnosis and treatment within the health system en_US
dc.type Article en_US
dc.citation.issue 2 en_US
dc.citation.jtitle Transactions of the Royal Society of Tropical Medicine and Hygiene en_US
dc.citation.volume 97 en_US
dc.citation.pages 146-152 en_US
dc.publisher.place Amsterdam
dc.identifier.pmid http://www.ncbi.nlm.nih.gov/pubmed/14584366
dc.identifier.url http://www.elsevier.com/locate/trstmh
dc.citation.jabbreviation Trans R Soc Trop Med Hyg en_US


Files in this item

Files Size Format View

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record